Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Jung-eun | - |
dc.contributor.author | Song, Chiman | - |
dc.contributor.author | Choi, Keehyun | - |
dc.contributor.author | Sim, Taebo | - |
dc.contributor.author | Moon, Bongjin | - |
dc.contributor.author | Roh, Eun Joo | - |
dc.date.accessioned | 2024-01-20T11:30:18Z | - |
dc.date.available | 2024-01-20T11:30:18Z | - |
dc.date.created | 2021-09-05 | - |
dc.date.issued | 2013-10-15 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/127545 | - |
dc.description.abstract | A series of 3,4-diarylpyrrolidin-2-one was designed, prepared and evaluated as triple reuptake inhibitors for antidepressant. Most compounds exhibited comparable in vitro efficacy as norepinephrine and dopamine transporter reuptake inhibitors. Especially, 2i showed better potency than GBR-12909 (IC50 = 14 - nM) which was used as reference compound for dopamine transporter. In addition, 2a and 2b showed inhibition (5.17 mu M-85.6 nM) for three transporters. (C) 2013 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.publisher | Pergamon Press Ltd. | - |
dc.subject | PHARMACOLOGICAL EVALUATION | - |
dc.subject | MAJOR DEPRESSION | - |
dc.subject | PROFILE | - |
dc.subject | POTENT | - |
dc.subject | AGENTS | - |
dc.title | Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.bmcl.2013.08.062 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | Bioorganic & Medicinal Chemistry Letters, v.23, no.20, pp.5515 - 5518 | - |
dc.citation.title | Bioorganic & Medicinal Chemistry Letters | - |
dc.citation.volume | 23 | - |
dc.citation.number | 20 | - |
dc.citation.startPage | 5515 | - |
dc.citation.endPage | 5518 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000324304000008 | - |
dc.identifier.scopusid | 2-s2.0-84884282193 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | PHARMACOLOGICAL EVALUATION | - |
dc.subject.keywordPlus | MAJOR DEPRESSION | - |
dc.subject.keywordPlus | PROFILE | - |
dc.subject.keywordPlus | POTENT | - |
dc.subject.keywordPlus | AGENTS | - |
dc.subject.keywordAuthor | Triple reuptake inhibitors | - |
dc.subject.keywordAuthor | Monoamine | - |
dc.subject.keywordAuthor | Reuptake | - |
dc.subject.keywordAuthor | Depression | - |
dc.subject.keywordAuthor | Antidepressant | - |
dc.subject.keywordAuthor | Serotonin | - |
dc.subject.keywordAuthor | Dopamine | - |
dc.subject.keywordAuthor | Norepinephrine | - |
dc.subject.keywordAuthor | Lactam | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.